Chapter 5 - (Pharmacodynamics) Flashcards
Dose- Response Relationship
Dose-response relationship is graded. That is, as the dosage increases, the response becomes progressively larger. Because drug responses are graded, therapeutic
effects can be adjusted to fit the needs of each patient.
Affinity
Refers to the strength of the attraction between a drug and its receptor. Drugs with high affinity are strongly attracted to their receptors. Conversely, drugs with low affinity are weakly attracted.
Agonist
Agonists are molecules that activate receptors. Because neurotransmitters, hormones, and all other endogenous regulators of receptor function activate the receptors to which they bind, all of these compounds are considered agonists. When drugs act as agonists, they simply bind to
receptors and mimic the actions of the body’s own regulatory molecules
Antagonist
Antagonists produce their effects by preventing receptor
activation by endogenous regulatory molecules and drugs. Antagonists have virtually no effects of their own.
In terms of the modified occupancy theory, an antagonist is a drug with affinity for a receptor but with no intrinsic activity. Affinity allows the antagonist to bind to receptors, but lack of intrinsic activity prevents the bound antagonist from causing receptor activation.
Competitive (surmountable) antagonists
-bind reversibly to receptors. As their name implies, competitive antagonists produce receptor blockade by
competing with agonists for receptor binding. If an agonist and a competitive antagonist have equal affinity for a particular receptor, then the receptor will be occupied by whichever agent—agonist or antagonist—is present in the highest concentration. If there are more
antagonist molecules present than agonist molecules, antagonist molecules will occupy the receptors and receptor activation will be blocked. Conversely, if agonist molecules outnumber the antagonists, receptors will be occupied mainly by the agonist and little inhibition will occur.
Non-competitive (non-surmountable) antagonists
-bind irreversibly to receptors. The effect of
irreversible binding is equivalent to reducing the total number of receptors available for activation by an agonist. Because the intensity of the response to an agonist is proportional to the total number of receptors occupied, and because noncompetitive antagonists decrease the number of receptors available for activation, noncompetitive antagonists reduce the maximal response that an agonist can elicit. If sufficient antagonist is present, agonist effects will be blocked completely.
ED50
- Is the dose that is required to produce a defined therapeutic response in 50% of the population.
- The ED50 can be considered a standard dose and, as such, is frequently the dose selected for initial treatment. After evaluating a patient’s response to this standard dose, we can then adjust subsequent doses up or down to meet the patient’s needs.
- (ED50 is an abbreviation for average effective dose.)
Intrinsic activity
-Is the ability of a drug to activate a receptor
upon binding.
-Drugs with high intrinsic activity cause intense receptor activation. Conversely, drugs with low intrinsic activity cause only slight activation.
LD50
The average lethal dose, is the dose that is lethal to 50% of the animals treated.
Maximal efficacy
-is the largest effect that a drug can produce. Maximal
efficacy is indicated by the height of the dose-response curve.
Partial agonist
-Is an agonist that has only moderate intrinsic activity.
As a result, the maximal effect that a partial agonist can produce is lower than that of a full agonist.
Receptor
-is any functional macromolecule in a cell to which a drug binds to produce its effects.
Safety
-a small (or low) therapeutic index indicates that a drug is
relatively unsafe.
Selectivity
-a highly desirable characteristic of a drug, in that
the more selective a drug is, the fewer side effects it will produce.
-Selective drug action is possible, in large part, because drugs act through specific receptors.
Therapeutic Index
-The therapeutic index is a measure of a drug’s safety. The therapeutic index, determined using laboratory animals, is defined as the ratio of a drug’s LD50 to its ED50.